SCHEMBL9006232

SCHEMBL9006232

COc1ccc2nc3[nH]nc(C)c3c(Cl)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.50
CDK1 P06493 1/20 0.50
CDK4 P11802 1/20 0.50
CDK2 P24941 1/20 0.50
AKT1 P31749 1/20 0.50
DYRK1A Q13627 1/20 0.45
KDM4E B2RXH2 4/20 0.45
HSD17B10 Q99714 2/20 0.45
LMNA P02545 1/20 0.45
SLC2A1 P11166 1/20 0.44
NQO2 P16083 1/20 0.44
HTT P42858 1/20 0.43
NUDT1 P36639 1/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 3/20 0.42
RAD52 P43351 1/20 0.42
PDE10A Q9Y233 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18079552 0.86 AURKA (0.52) AURKACDK1CDK4CDK2AKT1
SCHEMBL9006085 0.82 POLB (0.49) AURKACDK1CDK4CDK2AKT1
SCHEMBL9006315 0.80 AURKA (0.46) AURKACDK1CDK4CDK2AKT1
SCHEMBL9006212 0.77 MAOA (0.48) AURKAKDM4EHSD17B10NUDT1RAD52
SCHEMBL12285138 0.76 KDM4E (0.55) DYRK1AKDM4EHSD17B10LMNASLC2A1
SCHEMBL9006235 0.74 HPGD (0.49) AURKACDK1CDK4CDK2AKT1
SCHEMBL9006179 0.74 PPARA (0.46) AURKACDK1CDK4CDK2AKT1
SCHEMBL14478787 0.74 LMNA (0.42) AURKACDK1CDK4CDK2AKT1
SCHEMBL7117733 0.73 CYP1A2 (0.65) KDM4EHSD17B10LMNASLC2A1NQO2
SCHEMBL22608957 0.73 NUDT1 (0.50) AURKACDK1CDK4CDK2AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9446039-B2 Aminoheteroaryl compounds as MTH1 inhibitors CEMM FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH (AT) 2016-09-20 US disclosed
US-20160015702-A1 AMINOHETEROARYL COMPOUNDS AS MTH1 INHIBITORS CEMM - FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH (AT) 2016-01-21 US disclosed
EP-2892530-A1 AMINOHETEROARYL COMPOUNDS AS MTH1 INHIBITORS CeMM - FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GmbH (AT) 2015-07-15 EP disclosed
WO-2014033136-A1 AMINOHETEROARYL COMPOUNDS AS MTH1 INHIBITORS CEMM - RESEARCH CENTER FOR MOLECULAR MEDICINE OF THE AUSTRIAN ACADEMY OF SCIENCES (AT) 2014-03-06 WO disclosed
US-5506236-A TREATING HERPES VIRUS INFECTIONS SCHERING CORPORATION 1996-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160015702-A1 AMINOHETEROARYL COMPOUNDS AS MTH1 INHIBITORS MTHFD1, NUDT15, NUDT1 AURKA 1692/4885CDK1 1615/4885CDK4 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.